DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Laxmi Cotspin Limited — Updates

NSE 1 hr ago·21 Aug 2026, 1:49 pm

Laxmi Cotspin

Laxmi Cotspin Limited has informed stock exchanges that its financial results for the quarter ending June 30, 2026, will be released in a readable format. This update clarifies that the company is preparing to disclose its quarterly performance data, ensuring it is presented in a clear and accessible manner for investors to review.

This announcement is significant for shareholders as it confirms the timeline for the release of crucial financial information. Access to clear and readable data allows retail investors to better analyze the company's operational performance and make more informed decisions regarding their investment in Laxmi Cotspin.

Investors should watch for the official filing of these results to understand the company's financial health and future outlook. The readability of the report will be key to interpreting the numbers accurately and assessing the stock's potential.